Precision Tests for Oncology
OncoAssure is a medical diagnostics company that identifies, develops, and commercialises clinically important biomarkers to significantly improve cancer management and treatment.
OncoAssure Molecular Diagnostics
Our lead product is a post-biopsy test for prostate cancer that measures the expression of genes that are key drivers of cancer progression.
The OncoAssure Process
OncoAssure aims to meet the most critical clinical needs by combining the latest transcriptomic and mathematical modelling techniques followed by stringent analytical and clinical validation.
Our Expertise in Oncology Molecular Diagnostics
The OncoAssure team have the key skills, expertise, and a proven track record in identifying, developing, and commercialising cancer biomarkers.
Latest News
Our Partners
